NCT05894161

Brief Summary

Background: Pain and sleep disturbance are the most common problems experienced by adult patients with sickle cell disease anemia. Aim: the aim of this study is to evaluate the efficacy of designed exercise program on pain, and quality of sleeping in adult patients with sickle cell disease anemia and how the program affects their quality of lives. Subjects and methods: Adults patients with sickle cell diseases aging over 18 years old. Data will be collected in face-to-face interviews. Eligible participants will be equally and randomized into two groups. Group-1: Twenty-five adult patients with SCD will receive a designed exercise program of physical therapy for relief pain and improve sleep quality (experimental group). The designed exercise program will be distributed on everyone. The recommendations will be to train from 30 to 45 minutes, three days per week for 6 weeks in addition to walking daily 30 minutes on the ground surface. Group-2: Twenty-five adult patients with SCD will participate as a control group they will not receive exercise program. Analysis: The collected data will be managed by using t -test and the repeated measures of ANOVA test to compare the significance within groups and between two groups.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 20, 2022

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 25, 2023

Completed
28 days until next milestone

Study Completion

Last participant's last visit for all outcomes

March 25, 2023

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

May 22, 2023

Completed
17 days until next milestone

First Posted

Study publicly available on registry

June 8, 2023

Completed
Last Updated

June 8, 2023

Status Verified

June 1, 2023

Enrollment Period

9 months

First QC Date

May 22, 2023

Last Update Submit

June 6, 2023

Conditions

Keywords

sleep disturbanceFatigueStressQuality of life

Outcome Measures

Primary Outcomes (2)

  • Pittsburgh Sleep Quality Index

    The (PSQI) is a 19-item instrument created to measure different aspects of sleep quality and sleep disturbance (Buysse, Reynolds, Monk, Berman, \& Kupfer, 1989). The scale reports quality of sleeping over the past month. The PSQI is divided into 7 subscale scores: subjective sleep quality; sleep latency (time of full sleep); duration; habitual sleep efficiency (proportion between total sleep time and time in bed); sleep disturbances (waking up during the night); use of medication to sleep; and daytime dysfunction (difficulty staying awake during daytime). The overall score ranges between 0 and 21, and a total score of more than 5 indicates poor sleep quality(Al Maqbali et al., 2020).

    10 minutes

  • Visual Analog Scale:

    VAS: It is a safe, valid, and reliable measurement instrument used to evaluate pain severity. It was designed by Huskisson to quantify values that could not be measured in numbers. The most important advantage of the test is the lack of a language barrier and simplicity of application. The definition of the parameter to be assessed is written at the two ends of a 10 cm line, and the patient marks on the line the point that they feel represents their perception of their current state. The VAS score is determined by measuring in millimeters from the left hand end of the line to the point that the patient marks (Kazak and Ozkaraman, 2021, Crichton, 2001).

    5 minutes

Secondary Outcomes (3)

  • WHOQOL-BREF:

    5 minutes

  • The Fatigue Scale

    5 minutes

  • The Perceived Stress Scale

    3 minutes

Study Arms (2)

Group-I

EXPERIMENTAL

Group-1: Twenty-five adult patients with SCD will receive a designed exercise program of physical therapy for relief pain and improve sleep quality (experimental group). The designed exercise program will be distributed on everyone. The recommendations will be to train from 30 to 45 minutes, 3 days per week for 6 weeks in addition to walking 30 minutes on the ground surface daily.

Other: Exercise training program

Group-II

NO INTERVENTION

Group-2: Twenty-five adult patients with SCD will participate as a control group they will not receive exercise program.

Interventions

The designed exercise program will be distributed on everyone. The recommendations will be to train from 30 to 45 minutes, 3 days per week for 6 weeks in addition to walking 30 minutes on the ground surface daily. 1. Diaphragmatic Breathing Exercises: Diaphragmatic breathing (DBRT) or abdominal deep breathing is an expansion of the abdominal area rather than the thoracic area when breathing. 2. Progressive Muscle Relaxation (PMR): The physical element includes the tensing and relaxing of all muscle groups over the face, arms, trunk (abdomen \& chest) and legs. 3. A combination of stretching, stabilization and strengthening exercises of the pelvic-lumbar region: 4. Walking exercise: Walking on the ground surface for 30 minutes every day.

Group-I

Eligibility Criteria

Age18 Years - 55 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • SCD patient
  • Their age from18 -55 years
  • have no communication problems
  • They able to perform the exercises

You may not qualify if:

  • Their age less than 18
  • They unable to do the exercises.
  • They had communication problems

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

IAU

Dammam, Estern, Saudi Arabia

Location

MeSH Terms

Conditions

Anemia, Sickle CellParasomniasFatigue

Condition Hierarchy (Ancestors)

Anemia, Hemolytic, CongenitalAnemia, HemolyticAnemiaHematologic DiseasesHemic and Lymphatic DiseasesHemoglobinopathiesGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesSleep Wake DisordersNervous System DiseasesMental DisordersSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Alsayed Shanb, Phd

    Associate professor in CAMS in IABF university

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
To prevent human bias regarding to participants and outcomes assessor
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
ealshurafa

Study Record Dates

First Submitted

May 22, 2023

First Posted

June 8, 2023

Study Start

May 20, 2022

Primary Completion

February 25, 2023

Study Completion

March 25, 2023

Last Updated

June 8, 2023

Record last verified: 2023-06

Data Sharing

IPD Sharing
Will not share

General data not individualized

Locations